Objective: The aim of this study was to test the predictive value of a Thyroid Imaging Reporting and Data System (TI-RADS) for malignant thyroid nodules.
Introduction
Thyroid nodules have become increasing common. To evaluate these nodules, the optimal technique is believed to be high-resolution ultrasonography 1 3 , and research has focused on identifying reliable ultrasonographic features to predict malignant potential and guide further clinical decision-making. The Thyroid Imaging Reporting and Data System (TI-RADS) was proposed in 2009 4, 5 , and many clinical studies have examined its various methods of classification 1,6 8 . However, these classification methods are complex and difficult to master and have been slowly accepted. Individual ultrasonographic signs that have been associated with malignant thyroid nodules include a height-to-width ratio>1, marked hypoechogenicity, microcalcifications, and irregular borders 9 11 . With these signs we formulated a simple TI-RADS classification scheme for determining the risk of malignancy in thyroid nodules. To test the feasibility of the TI-RADS classification method we compared the results with surgical pathology reports.
Methods

Patients
Enrolled as subjects for this study were patients who had undergone thyroidectomy at the Affiliated Union 
Ultrasonography protocol
Multislice scanning of the bilateral thyroid lobes and isthmus was performed with a color Doppler ultrasonography system (GE LOGIQ E9, GE Medical Systems, Milwaukee, WI, USA, or Toshiba Aplio 500, Toshiba
Medical Systems Co., Tochigi, Japan) with 10-to 14-MHz linear array high-frequency probes. The examinations were performed in the preset thyroid mode, and the gain, depth, and focusing sites were adjusted according to patient-specific circumstances to ensure that the images would be displayed clearly. Examinations were performed with the patient in a supine position and the patient's head leaning back to fully expose the anterior part of the neck. Each nodule was described in detail according to location, size, relationship with the capsule, shape, height-to-width ratio, edges, borders, structural components, echogenicity, and calcifications. The cervical lymph nodes were sequentially scanned, and ultrasonographic features of the lymph nodes were recorded. All images were stored in a PACS workstation.
Ultrasonographic criteria for the TI-RADS
Based on ultrasonographic findings of malignant thyroid nodule that well accepted in the correlative literature 9 12 , the following ultrasonographic signs were chosen to assess the possible malignancy of the nodule: (1) (6) signs of metastasis to the cervical lymph nodes, including microcalcifications, liquefied zones, and diffuse or focal hyperechoic areas (Fig. 1) .
TI-RADS classification
According to the ultrasonographic features, nodules were classified with the TI-RADS into a total of 6 categories: an incomplete category (category 0) and 5 complete final categories (categories 1 5). 
Statistical analysis
The SPSS software package (SPSS for Windows, version 16.0; SPSS Inc., Chicago, IL, USA) was used to analyze the relevant data. The t-test was used to compare the differences in age and nodule size between patients with benign or malignant nodules, and the χ 2 test or 
Results
Relationship between histopathological diagnoses and TI-RADS category
Included in the study were 910 thyroid nodules, of which 370 were benign and 540 (59.34%) were malignant, from 812 patients. The relationship between histopathological diagnoses and TI-RADS category is shown in nodules were more common in female patients than in male patients; however, the male/female ratios of benign Note: The comparison of 6 sonographic features between the benign and malignant groups appear to be statistically significant (P=0.000, using the chi-square test). Number in parenthesis is percent of nodules with this factor to be this type of nodule. 
=0.001, P=0.976).
The following ultrasonographic features of malignancy were significantly more common (χ 2 test, P=0.000) among malignant nodules than among benign nodules: heightto-width ratio>1, microcalcifications, marked hypoechogenicity, irregular borders, breach of the thyroid capsule, and lymph node metastases. The sensitivities and specificities, respectively, of the 6 malignant ultrasonic signs in diagnosing malignant thyroid nodules were as follows:
height-to-width ratio>1, 33% and 96%; microcalcification, 48% and 84%; irregular margin, 76% and 76%; extremely low echo, 16% and 99%; nodule-breakthrough thyroid capsule, 11% and 99%; and lymph node metastasis, 18%
and 99% ( Table 2) .
Relationship between TI-RADS category and ultrasonographic features of malignancy
The number of nodules of each category was as follows ( (Fig. 2) , marked hypoechogenicity was rare in category 3a, height-to-width ratio>1 was common in categories 3b and 3c, and the occurrence microcalcifications and irregular borders increased with increasing TI-RADS category.
The proportion of malignant nodules in each TI-RADS category was gradually increased. The χ 2 test showed a significant difference in distribution of benign and malignant nodules among TI-RADS categories 2, 3a, 3b, and 3c (P=0.000) ( Table 3 ). The area under the receiver-operating curve for TI-RADS classification diagnosis was 0.894 (95% confidence interval, 0.874 0.915) (Fig. 3) Marked hypoechogenicity is a ultrasonographic feature that is specific to malignant thyroid nodules and is closely associated with papillary carcinoma 9, 18 . In the present study marked hypoechogenicity was rare among nodules in category 3a, indicating that this sign has an extremely low probability of appearing in thyroid nodules if other signs of malignancy are absent. Because cystic papillary thyroid cancer is extremely rare 19 and solid benign thyroid nodules are extremely common, a solid nodule cannot become a sign to assess benign and malignant nodules. Because color Doppler ultrasonography has no clear indicator for discriminating benign and malignant nodules 20 22 and because ultrasound elastography technology is immature 23, 24 , these 2 modes were not used to examine the thyroid nodules included in the present study.
Standards of care dictate that when the risk of disease is low, such as<1% for acute coronary heart disease or 0.5% for breast cancer, further clinical evaluation is not needed. When the risk of thyroid cancer is being considered on the basis of ultrasonographic imaging, when can FNA cytology be avoided? 25 Rates of malignancy have varied from 1.7% to 29.8% among nodules classified with a TI-RADS as benign, from 3.3% to 80% among nodules classified as suspicious for malignancy, and from 64.8%
to 100% among nodules classified as highly suspicious for malignancy 4 6,12,14 . In the present study, the rates of histopathologically confirmed malignancy were 5.4% in nodules of TI-RADS category 2, 36% to 92% in nodules of category 3a to 3c, and 99.0% in nodules of category 4.
If nodules of category 2 were regarded as benign while those of categories 3 and 4 were regarded as malignant, the chance of misdiagnosis of malignancy was low (sensitivity=98% and negative predictive value=95%), but the false-positive rate was higher (specificity=48% and positive predictive value=73%). These results were probably due to the rate of malignancy among nodules classified as TI-RADS category 3a being as low as 36%. These results suggest that nodules in TI-RADS category 2, i.e., 
